Drug Profile
Monoclonal antibody B43 Genistein-conjugate
Alternative Names: B43-Gen; B43-Genistein; B43-Genistein conjugate; Monoclonal antibody B43-GenLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator University of Minnesota
- Developer Bristol-Myers Squibb; University of Minnesota
- Class Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action Protein tyrosine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma